160 related articles for article (PubMed ID: 1901482)
1. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection.
Wormser GP; Horowitz HW; Duncanson FP; Forseter G; Javaly K; Alampur SK; Gilroy SA; Lenox T; Rappaport A; Nadelman RB
Arch Intern Med; 1991 Apr; 151(4):688-92. PubMed ID: 1901482
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Martin MA; Cox PH; Beck K; Styer CM; Beall GN
Arch Intern Med; 1992 Mar; 152(3):523-8. PubMed ID: 1546914
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
4. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
[TBL] [Abstract][Full Text] [Related]
5. Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.
Thea DM; Lambert G; Weedon J; Matheson PB; Abrams EJ; Bamji M; Straus WL; Thomas PA; Krasinski K; Heagarty M
Pediatrics; 1996 Jan; 97(1):59-64. PubMed ID: 8545225
[TBL] [Abstract][Full Text] [Related]
6. [Prevention of Pneumocystis carinii pneumonia with intermittent trimethoprim-sulfamethoxazole].
Luzzati R; Raviglione MC
Minerva Med; 1992 Oct; 83(10):641-6. PubMed ID: 1461536
[TBL] [Abstract][Full Text] [Related]
7. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial.
Hibberd PL; Tolkoff-Rubin NE; Doran M; Delvecchio A; Cosimi AB; Delmonico FL; Auchincloss H; Rubin RH
Online J Curr Clin Trials; 1992 Aug; Doc No 15():[4083 words; 46 paragraphs]. PubMed ID: 1343609
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim.
Nielsen TL; Jensen BN; Nelsing S; Pedersen C; Mathiesen LR; Skinhøj P; Nielsen JO
Dan Med Bull; 1993 Sep; 40(4):503-5. PubMed ID: 8222772
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
[TBL] [Abstract][Full Text] [Related]
10. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients.
Lindemulder S; Albano E
Pediatrics; 2007 Jul; 120(1):e47-51. PubMed ID: 17606548
[TBL] [Abstract][Full Text] [Related]
11. Trimethoprim-sulfamethoxazole (TMP-SMZ) dose escalation versus direct rechallenge for Pneumocystis Carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with previous adverse reaction to TMP-SMZ.
Leoung GS; Stanford JF; Giordano MF; Stein A; Torres RA; Giffen CA; Wesley M; Sarracco T; Cooper EC; Dratter V; Smith JJ; Frost KR;
J Infect Dis; 2001 Oct; 184(8):992-7. PubMed ID: 11574913
[TBL] [Abstract][Full Text] [Related]
12. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis of Pneumocystis carinii pneumonia in patients infected with the human immunodeficiency virus type 1.
Montgomery AB
Semin Respir Infect; 1989 Dec; 4(4):311-7. PubMed ID: 2697054
[TBL] [Abstract][Full Text] [Related]
14. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
Glatt AE; Chirgwin K
Arch Intern Med; 1990 Feb; 150(2):271-9. PubMed ID: 2405800
[TBL] [Abstract][Full Text] [Related]
15. [Sulfamethoxazole-trimethoprim-induced pneumonitis in a patient with hemophilia B who was infected with the human immunodeficiency virus].
Yamagishi T; Yoshida S; Fukutake K; Utsumi K; Ichinose Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jul; 34(7):822-8. PubMed ID: 8810766
[TBL] [Abstract][Full Text] [Related]
16. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.
Madhi SA; Cutland C; Ismail K; O'Reilly C; Mancha A; Klugman KP
Clin Infect Dis; 2002 Nov; 35(9):1120-6. PubMed ID: 12384847
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Wordell CJ; Hauptman SP
Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
[TBL] [Abstract][Full Text] [Related]
18. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
19. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
Connelly RT; Lourwood DL
Pharmacotherapy; 1994; 14(4):424-9. PubMed ID: 7937279
[TBL] [Abstract][Full Text] [Related]
20. The treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
Small CB; Harris CA; Friedland GH; Klein RS
Arch Intern Med; 1985 May; 145(5):837-40. PubMed ID: 3873229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
